CDC5L anticorps (AA 109-303)

N° du produit ABIN968837

Détail du produit anti-CDC5L anticorps

Antigène: CDC5L (CDC5 Cell Division Cycle 5-Like (S. Pombe) (CDC5L))

Épitope: AA 109-303

Reactivité: Humain, Souris, Rat, Chien, Poulet

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CDC5L est non-conjugé

Application: Western Blotting (WB), BioImaging (BI)

Réactivité croisée: Poulet, Chien, Humain, Souris

Attributs du produit: 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. This antibody has been developed and certified for the bioimaging application. However, a routine bioimaging test is not performed on every lot. Researchers are encouraged to titrate the reagent for optimal performance.
3. Triton is a trademark of the Dow Chemical Company.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
5. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
6. Please refer to us for technical protocols.

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogène: Rat CDC5L aa. 109-303

Clone: 21-CDC5L

Isotype: IgG1

Information d'application

Indications d'application: Bioimaging
1. Seed the cells in appropriate culture medium at ~10,000 cells per well in an 96-well Imaging Plate and culture overnight.
2. Remove the culture medium from the wells, and fix the cells by adding 100 myl of Fixation Buffer to each well. Incubate for 10 minutes at room temperature (RT).
3. Remove the fixative from the wells, and permeabilize the cells using either 90% methanol, or Triton™ X-100: a. Add 100 myl of -20°C 90% methanol to each well and incubate for 5 minutes at RT. OR b. Add 100 myl of 0.1% Triton™ X-100 to each well and incubate for 5 minutes at RT.
4. Remove the permeabilization buffer, and wash the wells twice with 100 myl of 1× PBS.
5. Remove the PBS, and block the cells by adding 100 myl of to each well. Incubate for 30 minutes at RT.
6. Remove the blocking buffer and add 50 myl of the optimally titrated primary antibody (diluted in Stain Buffer) to each well, and incubate for 1 hour at RT.
7. Remove the primary antibody, and wash the wells three times with 100 myl of 1× PBS.
8. Remove the PBS, and add the second step reagent at its optimally titrated concentration in 50 myl to each well, and incubate in the dark for 1 hour at RT.
9. Remove the second step reagent, and wash the wells three times with 100 myl of 1× PBS.
10. Remove the PBS, and counter-stain the nuclei by adding 200 myl per well of 2 myg/ml Hoechst 33342 in 1× PBS to each well at least 15 minutes before imaging.
11. View and analyze the cells on an appropriate imaging instrument.

Commentaires:

Related Products: ABIN968546, ABIN967389

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 250 μg/mL

Buffer: Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store undiluted at -20°C.

Références pour anticorps anti-CDC5L (ABIN968837)

Ajuh, Sleeman, Chusainow, Lamond: "A direct interaction between the carboxyl-terminal region of CDC5L and the WD40 domain of PLRG1 is essential for pre-mRNA splicing." dans: The Journal of biological chemistry, Vol. 276, Issue 45, pp. 42370-81, (2001) (PubMed).

Ajuh, Kuster, Panov, Zomerdijk, Mann, Lamond: "Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry." dans: The EMBO journal, Vol. 19, Issue 23, pp. 6569-81, (2000) (PubMed).

Boudrez, Beullens, Groenen, Van Eynde, Vulsteke, Jagiello, Murray, Krainer, Stalmans, Bollen: "NIPP1-mediated interaction of protein phosphatase-1 with CDC5L, a regulator of pre-mRNA splicing and mitotic entry." dans: The Journal of biological chemistry, Vol. 275, Issue 33, pp. 25411-7, (2000) (PubMed).

Bernstein, Coughlin: "Pombe Cdc5-related protein. A putative human transcription factor implicated in mitogen-activated signaling." dans: The Journal of biological chemistry, Vol. 272, Issue 9, pp. 5833-7, (1997) (PubMed).

Détails sur CDC5L

Antigène: CDC5L (CDC5 Cell Division Cycle 5-Like (S. Pombe) (CDC5L))

Autre désignation: CDC5L (CDC5L Produits)

Synonymes: anticorps zgc:55853, anticorps CDC5L, anticorps CDC5, anticorps CDC5-LIKE, anticorps CEF1, anticorps PCDC5RP, anticorps dJ319D22.1, anticorps 1200002I02Rik, anticorps AA408004, anticorps ARABIDOPSIS THALIANA CELL DIVISION CYCLE 5, anticorps ARABIDOPSIS THALIANA MYB DOMAIN CELL DIVISION CYCLE 5, anticorps ATCDC5, anticorps ATMYBCDC5, anticorps F21M12.15, anticorps F21M12_15, anticorps cell division cycle 5, anticorps CDC5 cell division cycle 5-like (S. pombe), anticorps cell division cycle 5 like, anticorps cell division cycle 5-like, anticorps cell division cycle 5 like S homeolog, anticorps cell division cycle 5-like (S. pombe), anticorps cell division cycle 5, anticorps cdc5l, anticorps CDC5L, anticorps Chro.50385, anticorps Cdc5l, anticorps cdc5l.S, anticorps CDC5

Sujet: Splicing, the removal of introns from pre-mRNA, is mediated by spliceosomal complexes and occurs in two distinct catalytic steps. The first step involves cleavage of the 5' exon and the production of a lariat intermediate. In the second step, the 3'-splice site is cleaved and the exons are fused with concomitant release of the intron lariat. The spliceosome contains multiple snRNPs and a number of non-snRNP splicing factors. CDC5L is a non-snRNP component of the splicesome that is homologous to the yeast Cdc5 protein. The sequence for CDC5L contgains a helix-turn-helix DNA binding domain (DBD), four nuclear localization signals, and a hydrophilic, proline-rich central region that is similar to the transcriptional activating domain in Myb family transcription factors. CDC5L can interact with the nuclear PP1 inhibitor NIPP-1 and the WD40 domain protein PLRG1. Both of these interactions are critical for pre-mRNA splicing and may also be important for G 2/M phase transition. In addition, CDC5L translocates from the cytoplasm to the nucleus in the presence of serum. Thus, CDC5L localization and splicesome-regulating activity may be controlled by mitogen-activated signal transduction pathways.

Poids moléculaire: 105 kDa

Pathways: Activation of Innate immune Response, Chromatin Binding